RxDoctor Payments Data

Mila Means, MD

Family Medicine · Wichita, KSNPI 1770565400

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $240,573 of the $240,896 with a category attached, or 99.9%. 9 manufacturers reported payments, led by CSL Behring at 53.4% of the total. Among family medicine clinicians in KS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$240,896in general payments, 2019–2025

Across 283 payments — averaging $851.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • CSL Behring$129K
  • CSL Plasma Inc.$112K
  • Radius Health, Inc.$100
  • Pfizer$51
  • Lilly USA, LLC$42
  • AstraZeneca$25
  • plus $45 from 3 others

What the payments were for

  • Consulting fees$240,573100%
  • Food & beverage$2640%
  • Education$600%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$240,896 in reported general payments places this provider in the 95th percentile of 1,469 family medicine providers in Kansas.

See all family medicine providers in Kansas

Medicare billing

Part B allowed, 2024
$60,769
Medicare patients
106
Services billed
781

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide56$59,001
FarxigaDapagliflozin Propanediol68$38,863
JardianceEmpagliflozin24$27,992
Xigduo XrDapaglifloz Propaned/Metformin25$20,672
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl73$13,408
EliquisApixaban18$11,310
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$11,000
MounjaroTirzepatide11$10,536
ArexvyRsvpref3 Antigen/As01e/Pf32$9,765
VeozahFezolinetant12$6,276
ShingrixVaricella-Zoster Ge/As01b/Pf24$5,175
Esomeprazole Magnesium14$2,798
Atorvastatin Calcium275$2,186
Bupropion XlBupropion Hcl71$2,002
Adacel TdapDiph,pertuss(Acell),tet Vac/Pf26$1,786

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$14$59,00156 claims
AstraZenecaFarxiga$25$38,86368 claims
PfizerEliquis$51$11,31018 claims
Lilly USA, LLCMounjaro$42$10,53611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,469 family medicine providers in Kansas.

Other family medicine in Wichita

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →